Ontology highlight
ABSTRACT: Background
Continuous α1a-blockade is the first-line treatment for lower urinary tract symptoms (LUTS) among older men with suspected benign prostatic hyperplasia. Variable efficacy and safety for individual men necessitate a more personalized, data-driven approach to prescribing and deprescribing tamsulosin for LUTS in older men.Objective
We aim to evaluate the feasibility and usability of the PERSONAL (Placebo-Controlled, Randomized, Patient-Selected Outcomes, N-of-1 Trials) mobile app for tracking daily LUTS severity and medication side effects among older men receiving chronic tamsulosin therapy.Methods
We recruited patients from the University of California, San Francisco health care system to participate in a 2-week pilot study. The primary objectives were to
SUBMITTER: Lee AW
PROVIDER: S-EPMC8709917 | biostudies-literature | 2021 Dec
REPOSITORIES: biostudies-literature